Strategies for Managing Cytopenias and Infection Prophylaxis with CAR-T Therapy
The conversation examines adverse events beyond CRS and neurotoxicities in CAR-T therapy, focusing on strategies for managing prolonged cytopenias, infection prophylaxis, and unique adverse events associated with ide-cel and cilta-cel.
Video content above is prompted by the following:
- Beyond CRS and neurotoxicities, are there other adverse events that require particular attention?
- How do you address prolonged cytopenias following CAR-T infusion?
- What is your approach to infection prophylaxis and management in these patients?
- Are there any distinct adverse events associated specifically with ide-cel or cilta-cel that clinicians should be aware of?
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
